BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 6178696)

  • 21. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological study of latent carcinoma--with special reference to prostatic cancer].
    Moriwaki S; Yamamoto Y; Takashima S; Uyama K; Higa I; Kanayama H
    Gan No Rinsho; 1985 Jun; 31(7):847-53. PubMed ID: 2411968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory studies for the detection of carcinoma of the prostate.
    Brawer MK
    Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical identification of prostatic epithelial cells in culture.
    Pontes JE; Choe B; Rose N; Pierce JM
    Invest Urol; 1979 May; 16(6):483-5. PubMed ID: 87387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of five tests to diagnose prostate cancer.
    Guinan P; Ray P; Bhatti R; Rubenstein M
    Prog Clin Biol Res; 1987; 243A():551-8. PubMed ID: 2443922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J; Jávor A
    Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H; Noma A; Nakauchi K; Mori M
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate-specific acid phosphatase in Nigerian patients with prostate carcinoma.
    Bolarin DM; Badejo OA
    East Afr Med J; 1985 May; 62(5):332-7. PubMed ID: 2412782
    [No Abstract]   [Full Text] [Related]  

  • 31. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J; Lorente JA; Reig C; López Pacios MA; de Torres JA; Soler Roselló A
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of acid phosphatase in prostatic carcinoma].
    Bauer HW; Walther V; Schmiedt F
    Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The laboratory diagnosis of prostatic adenocarcinoma.
    Griffiths JC
    Crit Rev Clin Lab Sci; 1983; 19(3):187-204. PubMed ID: 6144453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
    Fuse H; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
    Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
    Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
    Rubenstein M; Guinan PD; McKiel CF; Dubin A
    Clin Physiol Biochem; 1988; 6(5):241-52. PubMed ID: 2465864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry in the diagnosis of difficult cases of prostatic cancer.
    Caillaud JM; Mathieu MC; Carlu C
    Prog Clin Biol Res; 1987; 243A():477-83. PubMed ID: 2443919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.